Kemin’s immune-health ingredient BetaVia Complete now approved as Novel Food in Thailand
The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.
Kemin (Des Moines, IA) reports that the Thailand Food and Drug Administration (TFDA) has approved Kemin’s BetaVia Complete immune health ingredient, granting it Novel Food status. The algae-derived beta-glucan ingredient can now be used in food supplements for humans in Thailand at a daily dose of 375 mg.
“BetaVia Complete is derived from Euglena gracilis, Kemin’s proprietary strain of algae known for its high level of beta-1,3-glucan and protein content, which also contains essential fatty acids,” the company’s press release states.
BetaVia also holds regulatory approvals in the U.S. and European Union. The ingredient “helps train the body’s natural defenses, supports respiratory tract health, and protects intestinal barrier integrity,” the press release states.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.
